Eva M Wojcik
Overview
Explore the profile of Eva M Wojcik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regmi A, Mehta M, Farooq A, Turk T, Wojcik E, Picken M
Arch Pathol Lab Med
. 2024 May;
149(2):191-194.
PMID: 38724031
Context.—: Localized amyloidosis of the bladder is rare and often mimics bladder malignancy. It is typically associated with the extracellular deposition of monoclonal light chains, either κ or λ. The...
2.
Renshaw A, Jorda M, Wojcik E, Pitman M
Cancer Cytopathol
. 2023 Jul;
132(2):84-86.
PMID: 37523299
No abstract available.
3.
Kurtycz D, Wojcik E, Rosenthal D
J Am Soc Cytopathol
. 2022 Oct;
12(1):66-74.
PMID: 36274039
Introduction: An international panel of experts in the field of urinary cytopathology conducted a survey, supported by the American Society of Cytopathology, to seek opinions, gather evidence, and identify practice...
4.
Trabzonlu L, Chatt G, McIntire P, Eshraghi R, Lapadat R, Atieh M, et al.
J Am Soc Cytopathol
. 2022 Apr;
11(4):218-225.
PMID: 35469774
Introduction: Telecytology offers a suitable solution to the cost and time efficiency questions on rapid onsite evaluation (ROSE). An increasing number of institutions are adopting new telecytology systems to meet...
5.
McIntire P, Aragao A, Burns B, Pambuccian S, Wojcik E, Barkan G
Cancer Cytopathol
. 2022 Feb;
130(5):363-369.
PMID: 35104393
Background: The Paris System for Reporting Urinary Cytology (TPS) uses hyperchromasia as major diagnostic criterion for high-grade urothelial carcinoma (HGUC). The purpose of the study was to evaluate cases that...
6.
Wojcik E, Kurtycz D, Rosenthal D
J Am Soc Cytopathol
. 2022 Jan;
11(2):62-66.
PMID: 35094954
Following the amazing acceptance of The Paris System for Reporting Urinary Cytology (TPS), the second edition (TPS 2.0) was inevitable. Based on new studies since the publication of the first...
7.
Maleki Z, Saoud C, Viswanathan K, Kilic I, Tommola E, Griffin D, et al.
Cancer Cytopathol
. 2022 Jan;
130(5):370-380.
PMID: 35081269
Background: Pediatric salivary gland fine-needle aspiration (FNA) is uncommon with a higher frequency of inflammatory lesions and a small proportion of malignancies. This international, multi-institutional cohort evaluated the application of...
8.
Chen H, Lapadat R, Lastra R, Biernacka A, Reeves W, Mueller J, et al.
Acta Cytol
. 2021 Feb;
65(2):140-149.
PMID: 33535202
Background: Fine needle aspiration (FNA) of renal masses can distinguish between benign and malignant neoplasms in 73-94% of cases. Previous studies suggested the correct subclassification of renal cell carcinomas (RCCs)...
9.
Abro S, Nomani L, Wojcik E, Pambuccian S, Chatt G, Barkan G
J Am Soc Cytopathol
. 2020 Dec;
10(1):64-70.
PMID: 33279453
Introduction: The Paris System (TPS) for Reporting Urinary Cytology (UCyto) was published in 2016, but to date, no study addressing the unsatisfactory (UNSAT) category has been published. We aimed to...
10.
McIntire P, Kilic I, Pambuccian S, Wojcik E, Barkan G
J Am Soc Cytopathol
. 2020 Nov;
10(1):14-19.
PMID: 33221245
Introduction: The Paris System for Reporting Urinary Cytology (TPS) was developed for standardization purposes and it placed an emphasis on screening for high-grade urothelial carcinoma (HGUC). Since then, it has...